Ensilicated Technologies
Ensilicated Technologies is a startup headquartered in Bristol, United Kingdom, founded in 2021. It has won about £2.78m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Ensilicated Technologies has won about £2.78m in competitive Innovate UK grants since 2023.
- Antibodies Unchained: Cold-Chain Free and Patient-Friendly therapies (£712k, 2025)
- Heat proofing Immunity: Pioneering a Thermally Resilient Ensilicated mRNA-LNP Vaccine Platform (£1.78m, 2023)
- Vaccines Without Refridgeration (£289k, 2023)
R&D ecosystem
Ensilicated Technologies sits inside the Bristol region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Bristol
Related
- Innovation profile of Bristol
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Ensilicated Technologies do?
Ensilicated Technologies works in pharmaceuticals. Its Innovate UK projects include: Antibodies Unchained: Cold-Chain Free and Patient-Friendly therapies.
Where is Ensilicated Technologies based?
Ensilicated Technologies is headquartered in Bristol, United Kingdom.
When was Ensilicated Technologies founded?
Ensilicated Technologies was founded in 2021.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.